11. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1231,
2000,
Page 13-13
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
12. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1231,
2000,
Page 14-14
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
13. |
Eptifibatide in ESPRIT: landmark study to have huge impact on practice |
|
Inpharma Weekly,
Volume &NA;,
Issue 1231,
2000,
Page 15-16
Charles Bankhead,
Preview
|
|
摘要:
Glycoprotein (GP) IIb/IIIa receptor antagonists have proven highly effective for preventing clot formation and clot-associated complications during percutaneous coronary interventions. However, use of GP IIb/IIIa receptor antagonists for interventional procedures has been limited by the high cost of the standard therapeutic agent, abciximab. Investigators estimate that no more than 25% of patients undergoing percutaneous intervention in the US receive adjunctive IIb/IIIa inhibition. However, expanded use of new-generation GP IIb/IIIa receptor antagonists could occur as a result of findings from a large clinical trial showing a 37% reduction in clinical events in patients treated with eptifibatide ['Integrilin'], which costs considerably less than abciximab. Results of studies involving 2 other GP IIb/IIIa receptor antagonists were less favourable - neither lamifiban nor the oral agent sibrafiban demonstrated an overall benefit in treatment of patients with acute coronary syndromes, as reported at the 49th Annual Scientific Sessions of the American College of Cardiology (ACC) [Anaheim, US; March 2000].
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
14. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1231,
2000,
Page 16-16
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
15. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1231,
2000,
Page 17-17
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
16. |
Addition of candesartan cilexetil beneficial post-MI |
|
Inpharma Weekly,
Volume &NA;,
Issue 1231,
2000,
Page 18-18
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
17. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1231,
2000,
Page 19-19
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
18. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1231,
2000,
Page 20-20
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
19. |
Severe intestinal toxicity with docetaxel/vinorelbine regimen |
|
Inpharma Weekly,
Volume &NA;,
Issue 1231,
2000,
Page 21-21
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
20. |
US FDA news |
|
Inpharma Weekly,
Volume &NA;,
Issue 1231,
2000,
Page 22-22
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|